NOI for InvivoScribe IGH+IGK Clonality Mega-ABI Assays
Archived on March 4, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM EST
- Posted
- February 12, 2026
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of Health and Human ServicesOFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA)
Notice details
- Place of performance
- San Diego, California, 92121
- Last updated
- Nov 3, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75N91026Q00007
- Notice ID
- 8881351daedd45aca120d8e52c4a5f59
Description
NOTICE OF INTENT TO AWARD SOLE SOURCE THIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. This is a notice of intent to solicit and award a sole source contract under statutory authority 10 USC 2304(c)(1), set forth in Federal Acquisition Regulation 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The Government intends to solicit and award a sole source contract for InvivoScribe IGH+IGK Clonality Mega-ABI Assays to InvivoScribe. InvivoScribe is currently the only provider that carries the specific required IGH/ IGK kit that fits the need of NCI's molecular laboratories servicing the many protocols of the Clinical Center.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (1)
- Download
NOTICE OF INTENT Invivoscribe.pdf
123 KBAdded in Special Notice version 3Posted
Lifecycle
- 3Version 3Special NoticeArchivedCurrent
NOI for InvivoScribe IGH+IGK Clonality Mega-ABI Assays
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N91026Q00007
Archive Date
Mar 4, 2026